This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
OBI Pharma, Inc.
Drug Names(s): Globo H-CRM197 vaccine
Description: OBI-833 is a carbohydrate-based vaccine comprised of the complex carbohydrate, Globo H hexasaccharide 1 (Globo H), conjugated to DT-CRM197, a non-toxic, mutated form of diphtheria toxin (DT). Globo H is an antigen overexpressed on several types of cancer cells, and the DT portion of the vaccine is projected to increase the immunogenicity of the Globo H carbohydrate antigen.
Deal Structure: OBI licensed OBI-833 from Academia Sinica.
Pink Sheet Weekly Trademark Review July 12, 2016
Pink Sheet Weekly Trademark Review May 19, 2015
Pink Sheet Weekly Trademark Review September 10, 2013
Additional information available to subscribers only: